BioAtla (BCAB) Return on Equity [ROE] (2020 - 2025)
BioAtla (BCAB) posted Return on Equity [ROE] of -871.64% for Q1 2025, down 673.69 percentage points from -197.96% a year earlier and down 492.55 percentage points from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Return on Equity [ROE] (2020 - 2025) Analysis & Trends
For FY2024, BioAtla's Return on Equity [ROE] came in at -166.18%, down 67.88 percentage points from FY2023.
- Annual Return on Equity [ROE] has declined for four consecutive years, with a four-year change of -125.41 percentage points (FY2020 to FY2024).
- In prior years, BioAtla's Return on Equity [ROE] was -98.30% in FY2023 (-43.85 pp), -54.45% in FY2022 (-8.78 pp), -45.67% in FY2021 (-4.90 pp) and -40.77% in FY2020.
- The Q1 2025 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last 13 quarters, with an average year-over-year change of -194.42 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 2.81 percentage points; the weakest was Q1 2025, with a drop of 673.69 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -379.09% (Q4 2024), -301.01% (Q3 2024) and -257.73% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | BioAtla | 2.25 Mn | 2.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -871.64% |
| Dec 31, 2024 | -379.09% |
| Sep 30, 2024 | -301.01% |
| Jun 30, 2024 | -257.73% |
| Mar 31, 2024 | -197.96% |
| Dec 31, 2023 | -149.21% |
| Sep 30, 2023 | -113.12% |
| Jun 30, 2023 | -82.94% |
| Mar 31, 2023 | -65.14% |
| Dec 31, 2022 | -65.94% |
| Sep 30, 2022 | -66.56% |
| Jun 30, 2022 | -56.44% |
| Mar 31, 2022 | -50.72% |
| Dec 31, 2021 | -43.53% |
| Sep 30, 2021 | -43.60% |
| Jun 30, 2021 | -39.34% |
| Mar 31, 2021 | -23.87% |
| Dec 31, 2020 | -46.35% |
API Access
BioAtla Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();